Adrienne Stewart, MD
Dermatology · Denver, CONPI 1154454353
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $84,767 of the $102,409 with a category attached, or 82.8%. 22 manufacturers reported payments, led by Galderma Laboratories, L.p. at 47.4% of the total. Reporting peaked in 2023 at $42,172 and has fallen 82.8% since, to $7,268 in 2025. Among dermatology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $318.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$49K
- AbbVie$46K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
- Aclaris Therapeutics, Inc.$1K
- Sun Pharmaceutical Industries Inc.$922
- EPI Health, LLC$672
- plus $3K from 16 others
What the payments were for
- Consulting fees$6,1826%
- Speaking & faculty fees$84,76783%
- Travel & lodging$2,1852%
- Food & beverage$9,1849%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 80 | $48,563 |
| AbbVie(2 entities) | 75 | $46,418 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $1,731 |
| Aclaris Therapeutics, Inc. | 4 | $1,031 |
| Sun Pharmaceutical Industries Inc. | 54 | $922 |
| EPI Health, LLC | 5 | $672 |
| VYNE Pharmaceuticals Inc. | 11 | $385 |
| Pfizer | 9 | $363 |
| Sanofi | 13 | $363 |
| Regeneron Healthcare Solutions, Inc. | 6 | $359 |
| Almirall LLC | 8 | $283 |
| Merz North America, Inc. | 3 | $265 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $225 |
| Revance Therapeutics, Inc. | 3 | $214 |
| LEO Pharma Inc. | 16 | $201 |
| Incyte Corporation | 11 | $194 |
| Journey Medical Corporation | 1 | $95 |
| Dermira, Inc. | 2 | $47 |
| Biofrontera Inc. | 2 | $32 |
| Botanix SB Inc | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Organon | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AKLIEF$38,454
- TWYNEO$28,388
- ORACEA$28,315
- EPSOLAY$26,738
- BOTOX COSMETIC$3,278
- EPIDUO FORTE$3,140
- ALTRENO$1,500
- Rhofade$1,125
- BOTOX$786
- Sitavig$625
- Cloderm$625
- Minolira 105mg$625
- Minolira 135mg$625
- ESKATA$500
- DUPIXENT$344
- SOOLANTRA$264
- Winlevi$250
- AMZEEQ$248
- EUCRISA$235
- XEOMIN$148
How this compares
$102,409 in reported general payments places this provider in the 95th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 16 | $1,115 |
| Clobetasol Propionate | 22 | $813 |
| Doxycycline Hyclate | 28 | $508 |
| Ketoconazole | 28 | $502 |
| Triamcinolone Acetonide | 18 | $207 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Denver
- Drew TaylorDenver$135K
- Elizabeth ShurnasDenver$13K
- Carl DemidovichDenver$13K
- Elizabeth RobinsonDenver$11K
- Caroline HaganDenver$8K
- Lindsey BroussardDenver$7K
- Catherine CarreteroDenver$7K
- Channing HoodDenver$7K
- Marcjonathan SerotaLittleton$3.2M
- Ammon LarsenLoveland$620K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.